These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3745533)

  • 21. Determinants of unfavorable presentation of primary cutaneous melanoma.
    Fallah M; Kharazmi E; Thomsen H; Sundquist J; Hemminki K
    J Am Acad Dermatol; 2011 Jul; 65(1):e5-6. PubMed ID: 21679807
    [No Abstract]   [Full Text] [Related]  

  • 22. Nowadays a histological sub-typing of thin melanoma is demanded for a proper patient management.
    Piscioli F; Pusiol T; Roncati L
    J Plast Reconstr Aesthet Surg; 2016 Nov; 69(11):1563-1564. PubMed ID: 27639421
    [No Abstract]   [Full Text] [Related]  

  • 23. [Malignant melanoma--compared worldwide].
    Balch CM; Soong SJ; Shaw HM
    Chirurg; 1986 Oct; 57(10):601-5. PubMed ID: 3491743
    [No Abstract]   [Full Text] [Related]  

  • 24. Melanoma margins: the importance and need for more evidence-based trials.
    Johnson TM; Sondak VK
    Arch Dermatol; 2004 Sep; 140(9):1148-50. PubMed ID: 15381557
    [No Abstract]   [Full Text] [Related]  

  • 25. Sentinel-node biopsy in melanoma.
    Balch CM; Cascinelli N
    N Engl J Med; 2006 Sep; 355(13):1370-1. PubMed ID: 17005955
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Wong SL
    Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early diagnosis of metastatic disease in melanoma: does it make a difference?: Comment on "Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result".
    Wong JH
    JAMA Surg; 2013 May; 148(5):462. PubMed ID: 23325337
    [No Abstract]   [Full Text] [Related]  

  • 28. False negative and overall survival after sentinel lymph node biopsy in patients with cutaneous melanoma.
    Caracò C; Mori S; Celentano E; Mozzillo N
    Suppl Tumori; 2005; 4(3):S199. PubMed ID: 16437985
    [No Abstract]   [Full Text] [Related]  

  • 29. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma].
    Ann Dermatol Venereol; 1995; 122(5):250-8. PubMed ID: 8572461
    [No Abstract]   [Full Text] [Related]  

  • 30. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant melanoma of the skin. Changing clinical stage at presentation, 1955-1979.
    Hove LM; Akslen LA; Hartveit F
    Oncology; 1987; 44(3):156-8. PubMed ID: 3601317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A glimpse of future management of melanoma.
    Cochran AJ
    Arch Dermatol; 2009 Oct; 145(10):1176-7. PubMed ID: 19841407
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Richards PC; Maddox WA
    Cancer; 1979 Mar; 43(3):883-8. PubMed ID: 427730
    [No Abstract]   [Full Text] [Related]  

  • 34. Surgical management of cutaneous melanoma: current practice and impact on prognosis.
    Mosca PJ; Tyler DS; Seigler HF
    Adv Surg; 2004; 38():85-119. PubMed ID: 15515616
    [No Abstract]   [Full Text] [Related]  

  • 35. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutical options in malignant skin tumours].
    Stanisz H; Tilgen W; Rass K
    MMW Fortschr Med; 2009 Sep; 151(39):34-8. PubMed ID: 19831193
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
    Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
    Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanoma staging and sentinel lymph node biopsy.
    Forsea AM
    Acta Dermatovenerol Croat; 2010; 18(4):279-88. PubMed ID: 21251448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic importance of a second invasive primary melanoma according to tumour stage.
    Youlden DR; Baade PD; Aitken JF; Green AC; Khosrotehrani K
    Br J Dermatol; 2017 Dec; 177(6):e336-e337. PubMed ID: 28771669
    [No Abstract]   [Full Text] [Related]  

  • 40. Biopsy and survival of malignant melanoma.
    Rampen FH; van der Esch EP
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):385-8. PubMed ID: 3973139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.